全文获取类型
收费全文 | 3020篇 |
免费 | 204篇 |
国内免费 | 12篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 84篇 |
妇产科学 | 32篇 |
基础医学 | 347篇 |
口腔科学 | 78篇 |
临床医学 | 318篇 |
内科学 | 637篇 |
皮肤病学 | 58篇 |
神经病学 | 283篇 |
特种医学 | 117篇 |
外科学 | 566篇 |
综合类 | 16篇 |
一般理论 | 3篇 |
预防医学 | 192篇 |
眼科学 | 69篇 |
药学 | 179篇 |
中国医学 | 2篇 |
肿瘤学 | 205篇 |
出版年
2023年 | 20篇 |
2022年 | 34篇 |
2021年 | 81篇 |
2020年 | 56篇 |
2019年 | 91篇 |
2018年 | 100篇 |
2017年 | 81篇 |
2016年 | 90篇 |
2015年 | 90篇 |
2014年 | 112篇 |
2013年 | 176篇 |
2012年 | 219篇 |
2011年 | 265篇 |
2010年 | 160篇 |
2009年 | 124篇 |
2008年 | 182篇 |
2007年 | 184篇 |
2006年 | 188篇 |
2005年 | 196篇 |
2004年 | 171篇 |
2003年 | 141篇 |
2002年 | 136篇 |
2001年 | 31篇 |
2000年 | 27篇 |
1999年 | 28篇 |
1998年 | 25篇 |
1997年 | 23篇 |
1996年 | 9篇 |
1995年 | 12篇 |
1994年 | 14篇 |
1993年 | 15篇 |
1992年 | 10篇 |
1991年 | 11篇 |
1989年 | 10篇 |
1988年 | 10篇 |
1987年 | 9篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 6篇 |
1982年 | 4篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1976年 | 6篇 |
1975年 | 5篇 |
1970年 | 7篇 |
1969年 | 4篇 |
1968年 | 4篇 |
1967年 | 4篇 |
1966年 | 6篇 |
1965年 | 4篇 |
排序方式: 共有3236条查询结果,搜索用时 0 毫秒
1.
2.
The CCR5Delta32 allele is associated with reduced liver inflammation in hepatitis C virus infection.
O Wald O Pappo Z B Ari E Azzaria I D Wiess I Gafnovitch H Wald U Spengler E Galun A Peled 《European journal of immunogenetics》2004,31(6):249-252
CCR5Delta32 is a deletion mutation in the chemokine receptor CCR5. Liver inflammatory activity was found to be significantly reduced (P = 0.005) in Jewish Israeli patients infected with the hepatitis C virus (HCV) carrying the CCR5Delta32 allele. The CCR5Delta32 allele does not alter susceptibility to HCV infection; however, it may play a role in the progression and outcome of the disease. 相似文献
3.
Tom Lindfors Carita Kvarnström Ari Ivaska 《Journal of electroanalytical chemistry (Lausanne, Switzerland)》2002,518(2):131-138
Electrically conducting soluble polyaniline (PANI), containing different amounts of a bulky lipophilic cationic additive, tridodecylmethylammonium chloride (TDMACl), was studied by Raman (λexc=780 nm) and UV–vis spectroscopy. PANI was made simultaneously electrically conducting and soluble with bis[4-(1,1,3,3-tetramethylbutyl)phenyl]phosphoric acid in dichloromethane. The PANI membranes were prepared by drop casting on glassy carbon or ITO substrates. Raman and UV–vis measurements were carried out in a 0.1 M CaCl2 solution at potentials between 400 and ?600 mV (vs. SCE) at pH 6, or alternatively at the open circuit potential at pH 10. The results of Raman, UV–vis and cyclic voltammetric measurements confirm that the incorporation of TDMACl into the PANI membrane facilitates the oxidation and reduction of PANI. 相似文献
4.
Ast Gil; Goldblatt Drora; Waisman Ari; Sperling Ruth; Mozes Edna; Sperling Joseph 《International immunology》1994,6(8):1097-1105
5.
Biji Bahuleyan Ankamma Rao Ari George Chacko Roy Thomas Daniel 《Journal of clinical neuroscience》2007,14(9):895-898
Chiari I malformation (CM) associated with a cervico-thoracic syrinx due to supracerebellar arachnoid cyst has not been reported in the literature. We report such a case, managed by fenestration of the arachnoid cyst and foramen magnum decompression (FMD), aiming to reduce the inferiorly directed pressure on the cerebellum and eliminate the craniospinal pressure dissociation respectively. Imaging done post-operatively showed upward displacement of the cerebellar tonsils with a decompressed craniovertebral junction and disappearance of the syrinx. 相似文献
6.
Encephalopathy is a common complication of sepsis. However, little is known about the morphological changes that occur in the brain during sepsis. In this study, fecal peritonitis was induced in Wistar rats, which had been monitored for 4 h before their brains were removed and samples from the CA1 area taken. In addition to higher blood pressure with a decreasing pattern and a significant drop in rectal temperature, an increased heart rate and marked respiratory failure were observed. The tissue was investigated and compared with corresponding hippocampal samples taken from sham‐operated and not operated control groups. Significantly more peri‐microvascular edema was found in the hippocampal CA1 area in the septic group. The percentages of the peri‐microvascular edema were 158.57 ± 3.6%, 122.84 ± 1.5% and 120.24 ± 1.9% in the fecal peritonitis group, sham‐operated and not operated control groups, respectively. The results may suggest that the edema observed around the microvessels may participate in the pathogenesis of the septic encephalopathy probably by causing in the microvascular permeability characteristics. 相似文献
7.
8.
Itälä A Koort J Ylänen HO Hupa M Aro HT 《Journal of biomedical materials research. Part A》2003,67(2):496-503
A novel chemical etching method was recently developed to create a controlled microrough surface on porous bioactive glass implants. Our earlier in vitro studies showed enhanced attachment of osteoblast-like MG63 cells on a microrough bioactive glass surface. The purpose of our current study was to confirm the in vivo significance of surface microroughening for bone bonding of bioactive glass. Porous bioactive glass cones made of sintered microspheres were surgically implanted in the anterior cortex of rabbit femurs. Peripheral quantitative computed tomography (pQCT), biomechanical push-out testing, histomorphometry, and electron microscopy (BEI-SEM) were used to analyze bone ingrowth and osseointegration at 7, 10, 14, 28, 56, and 84 days after implantation. The results showed that microroughening of the bioactive glass surface significantly enhanced the bone-bonding response of the biomaterial. The positive response was seen in one of the three bioactive glass compositions studied. The affinity index of new bone on the glass surface was significantly (p = 0.02) increased with a trend (p = 0.10) toward improved mechanical incorporation. New bone formation was dependent on the glass composition, and it was found to occur not only through the mechanism of bone ingrowth but also based on in situ osteogenesis within implant interstices. Based on these results, the procedure of microroughening could enhance the osteopromotive properties of certain bioactive glass compositions. 相似文献
9.
O. Wald O. Pappo Z. B. Ari E. Azzaria I. D. Wiess I. Gafnovitch H. Wald U. Spengler E. Galun A. Peled 《International journal of immunogenetics》2004,31(6):249-252
CCR5Δ32 is a deletion mutation in the chemokine receptor CCR5. Liver inflammatory activity was found to be significantly reduced (P = 0.005) in Jewish Israeli patients infected with the hepatitis C virus (HCV) carrying the CCR5Δ32 allele. The CCR5Δ32 allele does not alter susceptibility to HCV infection; however, it may play a role in the progression and outcome of the disease. 相似文献
10.
Deborah Elstein Judith Guedalia Glen M Doniger Ely S Simon Vered Antebi Yael Arnon Ari Zimran 《Genetics in medicine》2005,7(2):124-130
PURPOSE: Because of concern for drug-induced cognitive dysfunction during clinical trials using substrate reduction therapy (miglustat) in type 1 Gaucher disease and because it has been suggested that some patients with type 1 Gaucher disease may develop neurocognitive impairment as part of the natural history, two different batteries of neuropsychological tests were devised to examine these issues. Using these tests, cognitive function was assessed in patients treated with miglustat, in patients receiving enzyme replacement (standard care for symptomatic patients), and in untreated (milder) patients. METHODS: For this study, 55/60 patients exposed to miglustat in Israel participated in psychologist-administered testing; 36/55 participated in computerized testing. Of these, 31 enzyme-treated patients and 22 untreated patients participated in the psychologist-administered testing, and 15 enzyme-treated patients and 18 untreated patients participated in computerized testing. The psychologist-administered battery consisted of 18 standard neuropsychological subtests specific to executive and visuospatial functioning. The computerized battery (Mindstreams, NeuroTrax Corp., New York, NY) consisted of 10 subtests tapping multiple cognitive domains. Between-group analyses for each modality compared cognitive performance. RESULTS: In the psychologist-administered testing, patients exposed to miglustat performed significantly less well than the other groups in 5/18 subtests. On the computerized tests, all patients performed comparably to normal controls. Scores in patients exposed to miglustat were higher than in untreated patients, particularly in visuospatial function, whereas enzyme-treated patients performed less well. However, with the exception of visuospatial function, these results were not statistically significant. CONCLUSIONS: It is unclear why different testing methods yielded discordant results. Any dysfunction suggested by the current study is apparently subtle and of doubtful clinical relevance given that cognitive status did not interfere with patients' daily intellectual function. The computerized battery has methodological advantages (e.g., language options, objectivity, brevity, and ease of use) that make it well-suited for longitudinal studies, for long-term surveillance of substrate reduction therapy as well as for comparisons with other lysosomal storage disorders and other chronic diseases. These preliminary findings should allay fears of cognitive dysfunction due to short-term miglustat therapy. 相似文献